Multicenter trial for assessing tolerability of combination therapy with cisplatin, irinotecan, and PSK in extensive-stage small-cell lung cancer: RNCLC-01 study.
Tatsuhiko Kashii
No relevant relationships to disclose
Toshiro Miwa
No relevant relationships to disclose
Shinya Kajiura
No relevant relationships to disclose
Ichiro Kinoshita
No relevant relationships to disclose
Satoshi Oizumi
No relevant relationships to disclose
Ken Nakagawa
No relevant relationships to disclose
Seisuke Nagase
No relevant relationships to disclose
Yusaku Akashi
No relevant relationships to disclose
Minoru Takada
No relevant relationships to disclose
Yasuo Iwamoto
No relevant relationships to disclose
Masahiro Tsuboi
No relevant relationships to disclose